NCT02213159View on ClinicalTrials.gov

Dexmedetomidine for Postoperative Analgesia After Bariatric Surgery

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

December 31, 2015

Conditions
ObesitySleep ApneaDiabetesHypertension
Interventions
DRUG

Dexmedetomidine

DRUG

Morphine

Trial Locations (1)

Unknown

American University of Beirut Medical Center, Beirut

All Listed Sponsors
lead

American University of Beirut Medical Center

OTHER

NCT02213159 - Dexmedetomidine for Postoperative Analgesia After Bariatric Surgery | Biotech Hunter | Biotech Hunter